Global Ovarian Cancer Therapeutics Market Research Report 2022

SKU ID : QYR-21348650 | Publishing Date : 18-Jul-2022 | No. of pages : 86

Request a free Sample

Detailed TOC of Global Ovarian Cancer Therapeutics Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 PARP
        1.2.3 PD-L1
        1.2.4 Angiogenesis Inhibitors
    1.3 Market by Application
        1.3.1 Global Ovarian Cancer Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hosptial
        1.3.3 Research
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ovarian Cancer Therapeutics Market Perspective (2017-2028)
    2.2 Ovarian Cancer Therapeutics Growth Trends by Region
        2.2.1 Ovarian Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ovarian Cancer Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Ovarian Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Ovarian Cancer Therapeutics Market Dynamics
        2.3.1 Ovarian Cancer Therapeutics Industry Trends
        2.3.2 Ovarian Cancer Therapeutics Market Drivers
        2.3.3 Ovarian Cancer Therapeutics Market Challenges
        2.3.4 Ovarian Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ovarian Cancer Therapeutics Players by Revenue
        3.1.1 Global Top Ovarian Cancer Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Ovarian Cancer Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Ovarian Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ovarian Cancer Therapeutics Revenue
    3.4 Global Ovarian Cancer Therapeutics Market Concentration Ratio
        3.4.1 Global Ovarian Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Therapeutics Revenue in 2021
    3.5 Ovarian Cancer Therapeutics Key Players Head office and Area Served
    3.6 Key Players Ovarian Cancer Therapeutics Product Solution and Service
    3.7 Date of Enter into Ovarian Cancer Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ovarian Cancer Therapeutics Breakdown Data by Type
    4.1 Global Ovarian Cancer Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Ovarian Cancer Therapeutics Breakdown Data by Application
    5.1 Global Ovarian Cancer Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ovarian Cancer Therapeutics Market Size (2017-2028)
    6.2 North America Ovarian Cancer Therapeutics Market Size by Country (2017-2022)
    6.3 North America Ovarian Cancer Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ovarian Cancer Therapeutics Market Size (2017-2028)
    7.2 Europe Ovarian Cancer Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Ovarian Cancer Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ovarian Cancer Therapeutics Market Size (2017-2028)
    9.2 Latin America Ovarian Cancer Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Ovarian Cancer Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bristol Myers Squibb Company
        11.1.1 Bristol Myers Squibb Company Company Detail
        11.1.2 Bristol Myers Squibb Company Business Overview
        11.1.3 Bristol Myers Squibb Company Ovarian Cancer Therapeutics Introduction
        11.1.4 Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.1.5 Bristol Myers Squibb Company Recent Development
    11.2 Eli Lilly and Company
        11.2.1 Eli Lilly and Company Company Detail
        11.2.2 Eli Lilly and Company Business Overview
        11.2.3 Eli Lilly and Company Ovarian Cancer Therapeutics Introduction
        11.2.4 Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.2.5 Eli Lilly and Company Recent Development
    11.3 GlaxoSmithKline Plc
        11.3.1 GlaxoSmithKline Plc Company Detail
        11.3.2 GlaxoSmithKline Plc Business Overview
        11.3.3 GlaxoSmithKline Plc Ovarian Cancer Therapeutics Introduction
        11.3.4 GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.3.5 GlaxoSmithKline Plc Recent Development
    11.4 Janssen Pharmaceuticals
        11.4.1 Janssen Pharmaceuticals Company Detail
        11.4.2 Janssen Pharmaceuticals Business Overview
        11.4.3 Janssen Pharmaceuticals Ovarian Cancer Therapeutics Introduction
        11.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.4.5 Janssen Pharmaceuticals Recent Development
    11.5 Genentech Inc.
        11.5.1 Genentech Inc. Company Detail
        11.5.2 Genentech Inc. Business Overview
        11.5.3 Genentech Inc. Ovarian Cancer Therapeutics Introduction
        11.5.4 Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.5.5 Genentech Inc. Recent Development
    11.6 Astra Zeneca
        11.6.1 Astra Zeneca Company Detail
        11.6.2 Astra Zeneca Business Overview
        11.6.3 Astra Zeneca Ovarian Cancer Therapeutics Introduction
        11.6.4 Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.6.5 Astra Zeneca Recent Development
    11.7 Boehringer Ingelheim GmbH
        11.7.1 Boehringer Ingelheim GmbH Company Detail
        11.7.2 Boehringer Ingelheim GmbH Business Overview
        11.7.3 Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Introduction
        11.7.4 Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.7.5 Boehringer Ingelheim GmbH Recent Development
    11.8 Hoffmann La Roche Ltd.
        11.8.1 Hoffmann La Roche Ltd. Company Detail
        11.8.2 Hoffmann La Roche Ltd. Business Overview
        11.8.3 Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Introduction
        11.8.4 Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2017-2022)
        11.8.5 Hoffmann La Roche Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Ovarian Cancer Therapeutics Market Research Report 2022

List of Tables
    Table 1. Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of PARP
    Table 3. Key Players of PD-L1
    Table 4. Key Players of Angiogenesis Inhibitors
    Table 5. Global Ovarian Cancer Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Ovarian Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Ovarian Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Ovarian Cancer Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Ovarian Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Ovarian Cancer Therapeutics Market Share by Region (2023-2028)
    Table 11. Ovarian Cancer Therapeutics Market Trends
    Table 12. Ovarian Cancer Therapeutics Market Drivers
    Table 13. Ovarian Cancer Therapeutics Market Challenges
    Table 14. Ovarian Cancer Therapeutics Market Restraints
    Table 15. Global Ovarian Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Ovarian Cancer Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Ovarian Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Therapeutics as of 2021)
    Table 18. Ranking of Global Top Ovarian Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Ovarian Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Ovarian Cancer Therapeutics Product Solution and Service
    Table 22. Date of Enter into Ovarian Cancer Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Ovarian Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Ovarian Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Bristol Myers Squibb Company Company Detail
    Table 43. Bristol Myers Squibb Company Business Overview
    Table 44. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Product
    Table 45. Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Bristol Myers Squibb Company Recent Development
    Table 47. Eli Lilly and Company Company Detail
    Table 48. Eli Lilly and Company Business Overview
    Table 49. Eli Lilly and Company Ovarian Cancer Therapeutics Product
    Table 50. Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Eli Lilly and Company Recent Development
    Table 52. GlaxoSmithKline Plc Company Detail
    Table 53. GlaxoSmithKline Plc Business Overview
    Table 54. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Product
    Table 55. GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. GlaxoSmithKline Plc Recent Development
    Table 57. Janssen Pharmaceuticals Company Detail
    Table 58. Janssen Pharmaceuticals Business Overview
    Table 59. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Product
    Table 60. Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Janssen Pharmaceuticals Recent Development
    Table 62. Genentech Inc. Company Detail
    Table 63. Genentech Inc. Business Overview
    Table 64. Genentech Inc. Ovarian Cancer Therapeutics Product
    Table 65. Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Genentech Inc. Recent Development
    Table 67. Astra Zeneca Company Detail
    Table 68. Astra Zeneca Business Overview
    Table 69. Astra Zeneca Ovarian Cancer Therapeutics Product
    Table 70. Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Astra Zeneca Recent Development
    Table 72. Boehringer Ingelheim GmbH Company Detail
    Table 73. Boehringer Ingelheim GmbH Business Overview
    Table 74. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Product
    Table 75. Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Boehringer Ingelheim GmbH Recent Development
    Table 77. Hoffmann La Roche Ltd. Company Detail
    Table 78. Hoffmann La Roche Ltd. Business Overview
    Table 79. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Product
    Table 80. Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Hoffmann La Roche Ltd. Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ovarian Cancer Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. PARP Features
    Figure 3. PD-L1 Features
    Figure 4. Angiogenesis Inhibitors Features
    Figure 5. Global Ovarian Cancer Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hosptial Case Studies
    Figure 7. Research Case Studies
    Figure 8. Ovarian Cancer Therapeutics Report Years Considered
    Figure 9. Global Ovarian Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Ovarian Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Ovarian Cancer Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Ovarian Cancer Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Ovarian Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Ovarian Cancer Therapeutics Revenue in 2021
    Figure 15. North America Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Ovarian Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Ovarian Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Ovarian Cancer Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Ovarian Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Ovarian Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Bristol Myers Squibb Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 44. Eli Lilly and Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 45. GlaxoSmithKline Plc Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 46. Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 47. Genentech Inc. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 48. Astra Zeneca Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 50. Hoffmann La Roche Ltd. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed

Keyplayers in Global Ovarian Cancer Therapeutics Market Research Report 2022

Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals
Genentech Inc.
Astra Zeneca
Boehringer Ingelheim GmbH
Hoffmann La Roche Ltd.